Gossamer Bio opened lower at $11.27, compared with its previous close of $11.69. In the last trading session, the stock traded between $10.60 and $12.15. It showed a downward intraday trend.
Return calculator
Time Period
An investment of $100 made 5 years ago in Gossamer Bio is now worth
$ 90.40
Resulting in a loss of
$ 9.60 (9.60%)
Invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
Rating from 3 Analysts
Buy
66.67%
Hold
33.33%
Sell
0%
Markets Today
Today's Change
$-0.53 (-4.49%)
Day High
$12.15
Day Low
$10.60
Day Open
$11.27
Prev Close
$11.69
Volume
1,74,146
1W Return
12.29%
1M Return
20.29%
3M Return
6,068.51%
6M Return
3,196.43%
1Y Return
331.08%
Fundamentals
Market Cap ($ Mn)
68
PE Ratio
-
PB Ratio
-
PEG Ratio
-
ROE
-
ROCE
-85.37%
EPS (TTM)
$2.77
Investment Returns
1 Week
12.29%
1 Month
20.29%
3 Months
6,068.51%
6 Months
3,196.43%
9 Months
375.11%
Financials
Quarterly
All values in $ Mn
9.9
Mar 25
11.5
Jun 25
13.3
Sep 25
13.8
Dec 25
17.0
Mar 26
9.2
Jun 26
Updates
11Nov
Gossamer Bio Q3 Results: Loss widens to $7.36; analysts cut targets
Gossamer Bio reported a Q3 loss of $7.36 per share, missing the consensus estimate of $3.68. Quarterly sales reached $38.431 million, beating the estimated $12.148 million. Piper Sandler cut its price target to $96 from $120, maintaining an Overweight rating. Wedbush lowered its price target to $32 from $80, maintaining a Neutral rating. Shares fell 4.7% to $10.75 following the earnings release.
Yesterday
11Nov
Wedbush maintains neutral on Gossamer Bio, cuts price target to $32
Wedbush analyst Laura Chico lowered Gossamer Bio's price target from $80 to $32. The firm maintained its Neutral rating on the company. The price target reduction represents a 60% decrease from the previous level.
Yesterday
11Nov
Gossamer Bio Q3 Results: EPS misses estimate by 100%, sales beat
Gossamer Bio reported Q3 EPS of $(7.36), missing the $(3.68) estimate by 100%. Quarterly sales of $38.431 million beat the $12.148 million consensus by 216.37%. Loss per share widened 3404.76% YoY from $(0.21) in the same period last year. Revenue grew 189.09% YoY from $13.294 million.
